These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27545696)

  • 41. Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity.
    Zhao Y; Feng G; Zhang J; Gong R; Cai C; Feng L
    Sci Rep; 2017 Sep; 7(1):12179. PubMed ID: 28939816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects.
    Favaloro EJ; Gilmore G; Bonar R; Dean E; Arunachalam S; Mohammed S; Baker R
    Haemophilia; 2020 Mar; 26(2):354-362. PubMed ID: 31962376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical utility of sample preheat treatment in a modified Nijmegen-Bethesda assay (mNBA) for inhibitor monitoring in congenital and acquired haemophilia A: A single-centre four-year experience.
    Gandhi T; Lawler P; Foxton E; Chowdary P; Riddell A
    Haemophilia; 2020 Nov; 26(6):e300-e307. PubMed ID: 32892451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents.
    Ten Boekel E; Böck M; Vrielink GJ; Liem R; Hendriks H; de Kieviet W
    Thromb Res; 2007; 121(3):361-7. PubMed ID: 17568658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. One-stage vs. chromogenic assays in haemophilia A.
    Potgieter JJ; Damgaard M; Hillarp A
    Eur J Haematol; 2015 Feb; 94 Suppl 77():38-44. PubMed ID: 25560793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
    Verbruggen B; Giles A; Samis J; Verbeek K; Mensink E; Novákovà I
    Thromb Haemost; 2001 Dec; 86(6):1435-9. PubMed ID: 11776311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of residual platelet count on routine coagulation, factor VIII, and factor IX testing in postfreeze-thaw samples.
    Lippi G; Rossi R; Ippolito L; Zobbi V; Azzi D; Pipitone S; Favaloro EJ; Funk DM
    Semin Thromb Hemost; 2013 Oct; 39(7):834-9. PubMed ID: 24022807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX-Padua.
    Robinson MM; George LA; Carr ME; Samelson-Jones BJ; Arruda VR; Murphy JE; Rybin D; Rupon J; High KA; Tiefenbacher S
    J Thromb Haemost; 2021 May; 19(5):1212-1218. PubMed ID: 33636038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
    Giles AR; Verbruggen B; Rivard GE; Teitel J; Walker I
    Thromb Haemost; 1998 Apr; 79(4):872-5. PubMed ID: 9569207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro detection of mild inhibitors to factor VIII in hemophilia.
    Ewing NP; Kasper CK
    Am J Clin Pathol; 1982 Jun; 77(6):749-52. PubMed ID: 6807080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of activated recombinant human factor 7 (Niastase) on laboratory testing of inhibitors of factors VIII and IX.
    Keeney M; Allan DS; Lohmann RC; Yee IH
    Lab Hematol; 2005; 11(2):118-23. PubMed ID: 16024335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haemophilia A and von Willebrand's disease.
    Goodeve AC; Rosén S; Verbruggen B
    Haemophilia; 2010 Jul; 16 Suppl 5():79-84. PubMed ID: 20590861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovaltry® and Jivi® Using CWA, Including sTF/7FIX Assay.
    Wada H; Shiraki K; Matsumoto T; Ohishi K; Shimpo H; Sakano Y; Nishii H; Shimaoka M
    Clin Appl Thromb Hemost; 2021; 27():1076029620976913. PubMed ID: 33606948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and quantification of factor VIII inhibitors.
    Verbruggen B
    Haemophilia; 2010 May; 16(102):20-4. PubMed ID: 19228204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Commutability of reference materials for coagulation factor VIII and factor IX activity on three measurement systems].
    Zhou W; Li C; Zhang H; Cheng F; Peng M
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2754-9. PubMed ID: 26711972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. One-Stage Factor VIII Assays.
    Duncan E; Rodgers S
    Methods Mol Biol; 2017; 1646():247-263. PubMed ID: 28804834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Screening and analysis of coagulation factor VIII inhibitor in patients with hemophilia A].
    Zhang AL; Yang LH; Liu XE; Zhao H; Zhang JH; Dong CX; Qi XL; Qin XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):968-70. PubMed ID: 21867625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimization of storage conditions for diluted working solutions of porcine factor VIII and performance of the Bethesda assay for the determination of antiporcine FVIII inhibitor titres.
    Winikoff R; Boulanger A; Robinson P; St-Louis J; Lacroix S; Rivard GE
    Haemophilia; 2003 Jan; 9(1):104-9. PubMed ID: 12558786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.